Bottom cards (Which this is) does not render the title text, so what you put here doesn't matter.

Are bed shortages forcing psychiatrists to find reasons to turn patients away? 

The challenge of delivering evidence‑based medicine in children’s care

How to navigate the NHS rules on weight loss drugs

Primary care has been divvied out bit by bit. What's left for GPs?

Analysis and Opinion

# The news that impacts UK doctors

Genetic testing for variants that cause dihydropyrimidine dehydrogenase (DPD) deficiency was recommended before prescribing fluoropyrimidine-based chemotherapy by the Medicines and Healthcare Products Regulatory Agency back in 2020. 

The NHS has incorporated a genetic variant more commonly found in people of African ancestry into a routine panel used to guide decisions on chemotherapy. 

Chemotherapy NHS gene test expanded to variant common in African ancestry

Log in or join for free to read more

You might also like